Hypertriglyceridemia During Anticancer Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia – A Nationwide Experience
Authors:
- Joanna ZawitkowskaJoanna Zawitkowska
- Eryk LatochELEryk Latoch
- Katarzyna KarskaKKKatarzyna Karska
- Katarzyna DrabkoKDKatarzyna Drabko
- Monika LejmanMLMonika Lejman
- Klaudia PaczóskaKPKlaudia Paczóska
- Tomasz OciepaTOTomasz Ociepa
- Anna MaleckaAMAnna Malecka
- Dorota SęGa-PondelDSDorota SęGa-Pondel
- Krzysztof KalwakKKKrzysztof Kalwak
- Katarzyna KonończukKKKatarzyna Konończuk
- Julia KołodrubiecJKJulia Kołodrubiec
Open Access
- 1 February 2026
- journal article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 18, 1-13
Abstract
In this study, we aimed to assess the demographics and incidence of hypertriglyceridemia (HTG) during acute lymphoblastic leukemia (ALL) treatment, complications related to HTG, and the treatment strategies applied in pediatric patients treated in pediatric hemato-oncology centers in Poland. A total of 72 out of 641 children, aged <18 years with ALL were diagnosed with HTG as a treatment-related complication. Statistical analyses were conducted with a significance level of α = 0.05. The emergence of HTG is a significant complication, with median peak triglyceride levels during treatment reaching 1385.00 mg/dL. Only 5.56% (n = 4) experienced complications. No patients developed pancreatitis. Treatment interruptions were minimal (a median 5.67 days). No children died due to HTG. Management strategies for HTG management included plasmapheresis in 8.3% (n = 6/72). Other therapies – insulin (23.6%, n = 17), heparin (34.7%, n = 25), fibrates (41.7%, n = 30), and omega-3 fatty acids (58.3%, n = 45). A correlation was observed between low antithrombin levels and high TG levels. This is the first nationwide, multicenter analysis conducted across pediatric hemato-oncology centers in Poland evaluating HTG during ALL therapy. HTG occurred in 11.1% of children in the analyzed cohort, and 72% of these cases were grade 3 or 4. With the management strategies applied, severe complications were uncommon and chemotherapy interruptions were generally short. Our findings support the effective triglyceride monitoring; however, triglyceride measurements are currently not standardized and are not performed at predefined time points during treatment. The observed association between low antithrombin levels and high triglyceride concentrations may help identify patients who require closer surveillance. Further prospective studies are needed to define risk factors, optimize prevention and treatment strategies and explore long-term outcomes.Keywords
This publication has 20 references indexed in Scilit:
- Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysisPediatric Blood & Cancer, 2023
- Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 2020
- Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaPediatric Blood & Cancer, 2019
- Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemiaTransfusion and Apheresis Science, 2019
- Asparaginase‐associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2016
- Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusThe Lancet Oncology, 2016
- Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemiaEuropean Journal of Cancer, 2014
- L-Asparaginase and Steroids-associated Hypertriglyceridemia Successfully Treated With Plasmapheresis in a Child With Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 2011
- Heparin and Insulin for Hypertriglyceridemia-Induced Pancreatitis: Case ReportThe Scientific World Journal, 2009
- Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresisPediatric Blood & Cancer, 2006